Sort
23,748 grants matching “melanoma”
The role of melanocyte precursors in zebrafish pigmentation disorders
$93,280Richard Mark White · Sloan-Kettering Inst Can Research · K08 · FY2012 · AR
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity
$93,263Jessica Lynn Fessler · Stanford University · K00 · FY2022 · CA
Cancer Immunology
$93,224Glenn Dranoff · Dana-Farber Cancer Inst · P30 · FY2015 · CA
Bioinformatics Core
$93,208Andrew V Kossenkov · Wistar Institute · U54 · FY2019 · CA
Cancer Immunology
$93,207Glenn Dranoff · Dana-Farber Cancer Inst · P30 · FY2012 · CA
Leukemia
$93,207A Thomas Look · Dana-Farber Cancer Inst · P30 · FY2012 · CA
Cancer Immunology
$93,190Glenn Dranoff · Dana-Farber Cancer Inst · P30 · FY2016 · CA
Asthma is a Prognostic Indicator for Pulmonary Metastasis of Breast Cancer
$93,178James Joseph Lee · Mayo Clinic Arizona · R03 · FY2009 · CA
Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
$93,163Josep Maria Domingo-Domenech · Thomas Jefferson University · R01 · FY2021 · CA
Administrative Core
$93,154Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Copper reduction as a novel therapy in BRAF-mutant positive cancers
$93,105Donita C Brady · Duke University · K01 · FY2013 · CA
Cancer Genomics Facility
$93,010William A Laframboise · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
MELANOCORTIN RECEPTOR-1 SPECIFIC 99MTC-METALLOPEPTIDES
$92,865Palatin Technologies, Inc. · R43 · FY2000 · CA
Evolutionary trajectories of tumors following resistance to immune checkpoint blockade
$92,836Melissa Quino Reeves · University Of California, San Francisco · R21 · FY2021 · CA
Administrative Core
$92,739Steven R Tannenbaum · Massachusetts Institute Of Technology · P01 · FY2013 · CA
CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS
$92,736City Of Hope/Beckman Research Institute · U10 · FY2004 · CA
Focused Ultrasound and Multifunctional Nanoparticle Vaccines as Adjuvant Strategies for Cancer Immunotherapy
$92,717Natasha Diba Sheybani · Stanford University · K00 · FY2021 · CA
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
$92,692Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
PROGRAM LEADERS
$92,675Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2010 · CA
Consolidated Basic Cancer Research Program
$92,630Dario C. Altieri · Wistar Institute · P30 · FY2014 · CA
NCI Patterns of Care (POC)/Quality of Care Study: Diagnosis Years 2017(NSCLC) and 2018 (NSCLC and Melanoma)
$92,596Kevin Ward · Emory University · N01 · FY2019 · CA
Targeting TERT in Melanoma
$92,585Jessie Villanueva · Wistar Institute · R01 · FY2019 · CA
Etiologic Studies of Diet and Cancer
$92,477Neal Freedman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
REGULATED EXPRESSION OF TENASCIN AND AVB6 IN ORAL CANCER
$92,288University Of California San Francisco · R29 · FY2001 · DE
Th9 cells as a promising effector T-cell subset for cancer therapy
$92,275Yong Lu · Cleveland Clinic Lerner Com-Cwru · K99 · FY2016 · CA